Advertisement
U.S. markets open in 6 hours 45 minutes

Insulet Corporation (PODD)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
171.68+5.82 (+3.51%)
At close: 04:00PM EDT
171.68 0.00 (0.00%)
After hours: 05:39PM EDT

Insulet Corporation

100 Nagog Park
Acton, MA 01720
United States
978 600 7000
https://www.insulet.com

Sector(s)Healthcare
IndustryMedical Devices
Full Time Employees3,000

Key Executives

NameTitlePayExercisedYear Born
Dr. James R. Hollingshead Ph.D.President, CEO & Director2.18MN/A1963
Ms. Shacey PetrovicDirector & Advisor2.96M12.99M1974
Mr. Eric BenjaminExecutive VP, Chief Product & Customer Experience Officer947.57kN/A1983
Ms. Lauren BuddenGroup VP, Chief Accounting Officer, Controller & Interim CFO and TreasurerN/AN/AN/A
Mr. Prem SinghSenior Vice President of Global OperationsN/AN/A1977
Mr. Mark FieldSenior VP & CTON/AN/AN/A
Ms. Deborah R. Gordon CPAVice President of Investor RelationsN/AN/A1970
Mr. John Wodick KapplesSenior VP & General Counsel783.36kN/A1960
Ms. Laetitia CousinSenior VP of Regulatory Affairs, Quality Assurance & ComplianceN/AN/A1976
Angela Geryak WiczekSenior Director of Corporate CommunicationsN/AN/AN/A
Amounts are as of December 31, 2022 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. The company's Omnipod platform includes the Omnipod 5 Automated Insulin Delivery System (Omnipod 5) which includes a proprietary AID algorithm embedded in the Pod that integrates with a third-party continuous glucose monitor to obtain glucose values through wireless bluetooth communication; Omnipod DASH that features a bluetooth enabled Pod that is controlled by a smartphone-like Personal Diabetes Manager with a color touch screen user interface; and Omnipod GO, a standalone, wearable, insulin delivery system that provides a fixed rate of continuous rapid-acting insulin for 72 hours. The company sells its products primarily through independent distributors and pharmacy channels, as well as directly in the United States, Canada, Europe, the Middle East, Australia, and internationally. Insulet Corporation was incorporated in 2000 and is headquartered in Acton, Massachusetts.

Corporate Governance

Insulet Corporation’s ISS Governance QualityScore as of March 1, 2024 is 9. The pillar scores are Audit: 6; Board: 7; Shareholder Rights: 10; Compensation: 8.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.